Crossmark

Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept

Crossref DOI link: https://doi.org/10.1007/s00296-018-4196-9

Published Online: 2018-11-10

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Generali, Elena https://orcid.org/0000-0002-5898-1767
Carrara, Greta https://orcid.org/0000-0001-9752-2275
Kallikourdis, Marinos https://orcid.org/0000-0001-9318-3368
Condorelli, Gianluigi https://orcid.org/0000-0003-0481-6843
Bortoluzzi, Alessandra https://orcid.org/0000-0003-2416-8134
Scirè, Carlo A. https://orcid.org/0000-0001-7451-0271
Selmi, Carlo https://orcid.org/0000-0002-0323-0376
License Information

Text and Data Mining valid from 2018-11-10
More Information

Article History

Received: 25 September 2018

Accepted: 2 November 2018

First Online: 10 November 2018

Compliance with ethical standards

:

: EG, GC, MK, GC, AB, CAS have none to declare; Carlo Selmi has been consulting for BMS and Pfizer.

: The present work was approved by IRB of University of Pavia, Italy (deliberation of 12/03/2012).